Increases in the use of drug testing kits among nightclub and festival attendees in New York City who use ecstasy, 2017–2022

Nicole D. Fitzgerald,Joseph J. Palamar
DOI: https://doi.org/10.1111/dar.13829
2024-02-28
Drug and Alcohol Review
Abstract:Introduction Ecstasy (3,4‐methylenedioxymethamphetamine [MDMA]) is a drug commonly used by people who attend electronic dance music (EDM) events at nightclubs and dance festivals. Drug checking has gained popularity in recent years to test for adulterants, but epidemiology studies are needed to estimate potential shifts in prevalence of drug checking to further inform harm reduction efforts. Methods Adults entering randomly selected EDM events in New York City were surveyed in 2017 and 2022. Those reporting past‐year ecstasy use were asked if they tested their ecstasy in the past year using a drug testing kit and whether they found out or suspected their ecstasy contained other drugs. We compared estimates between 2017 and 2022. Results In 2017, an estimated 23.1% had tested their ecstasy, and this estimate increased to 43.1% in 2022 (86.6% increase, p = 0.006). Among those who tested their ecstasy, in 2017, 31.2% always tested their drug, and this increased to 60.6% in 2022 (94.2% increase, p = 0.026). In 2017, 59.6% of those who tested their ecstasy reported finding out or suspecting their drug was adulterated, which decreased to 18.4% in 2022 (69.1% decrease, p
substance abuse
What problem does this paper attempt to address?